Our Media: to stream
Latest content from Pharmetheus.
Short introduction to Pharmetheus 2021
With an early focus on Pharmacometrics, we have over the years broadened our focus to a range of different services In this video, our CEO and COB share our vision, mission, strengths and other facts through the voice of Sofia Friberg Hietala.
Introduction to our MIDD framework
We are advancing model informed drug development.
In this video, Peter Milligan describes our framework and some benefits of adopting these solutions across the project portfolio in terms of improved decision making, efficiency and return of investment.
Introduction to Pharmetheus
How well do you know Pharmetheus?
Pharmetheus' journey is worth sharing. In this video, Elodie Plan and Marie Sandström explain who we are and where we are heading.
Poster presentation
Population RTTE analysis of exacerbations in asthma patients
Pharmetheus co-authored a poster on Population RTTE analysis of exacerbations in asthma patients. Watch our MIDD Consultant Robin Svensson presenting it for the American Conference on Pharmacometrics 2020.
COVID-19 clinical trial impact and potential mitigation
Fewer subjects, shorter duration, missingness patterns and dosing interruptions.
The ongoing pandemic continues to influence the conduct of clinical trials in all therapeutic areas. In this video, our Chief Statistician Richard Anziano describes how the COVID-19 impact on studies can be understood and mitigated, using modeling and simulation approaches.
